Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Impact of monoclonal antibody therapy for head and neck cancer on end‐of‐life care utilization and costs

Head & Neck(2023)10.1002/hed.27359Source: DataRank Database

Impact of monoclonal antibody therapy for head and neck cancer on end‐of‐life care utilization and costs is a research paper published in Head & Neck (2023). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.32)OA: bronzeTopics (39)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Pratyusha Yalamanchi ORCID,Jeremy M. G. Taylor ORCID,Nicholas R. Lenze ORCID,Francis P. Worden ORCID,Steven B. Chinn ORCID

Live enrichment

PubMed:36976786 PMC:PMC10314811 OpenAlex:https://openalex.org/W4361190780

National Cancer Institute

Grant: K08 17‐OAF07511

NCI NIH HHS

Grant: K08 CA226350

FWCI

0.32

Citation Percentile

0.7%

Citation Trend

2026

bronzeLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hed.27359

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hed.27359

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/hed.27359

journalhttps://doi.org/10.1002/hed.27359

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36976786

Fields of Study

Economic and Financial Impacts of CancerSafe Handling of Antineoplastic DrugsHead and Neck Cancer StudiesHumansAgedUnited StatesMedicareRetrospective StudiesTerminal CareHealth Care CostsHead and Neck NeoplasmsNivolumabDeath

MeSH Terms

NivolumabAgedDeathHead and Neck NeoplasmsMedicareHumansRetrospective StudiesTerminal CareUnited StatesHealth Care Costs

Keywords

Head and neck cancerHead and neckMonoclonal antibodyMedicineCancerHead (geology)OncologyIntensive care medicineSurgeryInternal medicineAntibodyImmunologyBiologyEnd-of-life CareHealth Care CostsHealth Care Utilization